RFC
IDIX

Russell Frank Company’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Russell Frank Company’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-26,298
Closed -$144K – 3395
2013
Q3 		$144K Buy
26,298
+3,370
+15% +$14.8K ﹤0.01% 2869
2013
Q2 		$83K Buy
+22,928
New +$93.8K ﹤0.01% 2791

Other funds holding IDIX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Russell Frank Company's IDIX Position: Q4 2013 in Review

Russell Frank Company sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q4 2013, closing a stake of 26,298 shares — an estimated $144K sold.

Russell Frank Company first reported a position in IDIX in Q2 2013 and held it in 2 quarters. The position peaked at $144K in Q3 2013. 88 funds tracked by Wall St. Rank hold IDIX as of Q4 2013.

  • Russell Frank Company reported no remaining IDENIX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Russell Frank Company sold 26,298 IDENIX PHARMACEUTICALS INC shares in Q4 2013, an estimated $144K.
  • Russell Frank Company first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Russell Frank Company's IDENIX PHARMACEUTICALS INC position peaked at $144K in Q3 2013.
  • 88 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q4 2013.

Based on Russell Frank Company's 13F filing for Q4 2013, filed 14 Feb 2014.